Clinical Trials Logo

Clinical Trial Summary

This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02932449
Study type Observational
Source Target PharmaSolutions, Inc.
Contact
Status Active, not recruiting
Phase
Start date October 2016
Completion date September 2026

See also
  Status Clinical Trial Phase
Recruiting NCT00242125 - Family Studies in Primary Biliary Cirrhosis (PBC) N/A
Terminated NCT02360852 - IBAT Inhibitor A4250 for Cholestatic Pruritus Phase 2
Recruiting NCT00145964 - Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC) N/A